Fennec Pharmaceuticals(TSE:FRX)
CA$16.56+0.51 (+3.18%)
TSE:FRX
Fennec Pharmaceuticals ownership
CA$16.56
At close:+0.51 (+3.18%)
Want to see TSE:FRX full AI Analyst Report?
Fennec Pharmaceuticals (FRX) Ownership - Who Owns Fennec Pharmaceuticals?
41 Followers
Fennec Pharmaceuticals (FRX) Ownership Overview
- 10.07% Insiders
- 5.04% Mutual Funds
- 6.48% ETFs
- 78.41% Public Companies and Individual Investors
The ownership structure of Fennec Pharmaceuticals (TSE:FRX) stock is a mix of institutional, retail, and individual investors. Approximately 11.52% of the company’s stock is owned by Institutional Investors, 10.07% is owned by Insiders, and 78.41% is owned by Public Companies and Individual Investors.
The ownership structure of Fennec Pharmaceuticals (TSE:FRX) stock is a mix of institutional, retail, and individual investors. Approximately 11.52% of the company’s stock is owned by Institutional Investors, 10.07% is owned by Insiders, and 78.41% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 30, 2026 | Pierre Sargis Sayad | $146,160 | |
| Dec 28, 2025 | Southpoint Capital Advisors Lp | $7,500,000 | |
| Nov 19, 2025 | Southpoint Capital Advisors Lp | $170,007 | |
| Nov 16, 2025 | Southpoint Capital Advisors Lp | $2,033,559 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Southpoint Capital Advisors Lp | 2,744,741 | Insider | 7.83% | 31,847,230 |
| Ishares | 1,115,312 | Institution | 3.18% | 12,940,965 |
| Vanguard | 1,018,393 | Institution | 2.90% | 11,816,414 |
| Vanguard Index Funds | 815,192 | Institution | 2.32% | 9,458,673 |
| Fidelity Salem Street Trust | 343,682 | Institution | 0.98% | 3,987,742 |
| Robert Andrade | 248,558 | Insider | 0.71% | 2,884,018 |
| Khalid Islam | 213,825 | Insider | 0.61% | 2,481,011 |
| Vanguard Scottsdale Funds | 200,194 | Institution | 0.57% | 2,322,851 |
| Rosty Raykov | 124,411 | Insider | 0.35% | 1,443,541 |
| Bridgeway Funds, Inc. | 108,005 | Institution | 0.31% | 1,253,182 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 815,192 | Institution | 2.32% | 9,458,673 |
| Fidelity Salem Street Trust | 343,682 | Institution | 0.98% | 3,987,742 |
| Vanguard Scottsdale Funds | 200,194 | Institution | 0.57% | 2,322,851 |
| Bridgeway Funds, Inc. | 108,005 | Institution | 0.31% | 1,253,182 |
| Schwab Capital Trust | 70,504 | Institution | 0.20% | 818,058 |
| Tiaa-cref Funds | 58,274 | Institution | 0.17% | 676,153 |
| Sei Institutional Investments Trust | 48,129 | Institution | 0.14% | 558,441 |
| Fidelity Concord Street Trust | 19,587 | Institution | 0.06% | 227,268 |
| Vanguard Valley Forge Funds | 14,096 | Institution | 0.04% | 163,556 |
| Valic Co I | 12,294 | Institution | 0.04% | 142,647 |
FAQ
Who Owns Fennec Pharmaceuticals (TSE:FRX)?
According to the latest TipRanks data, approximately 11.52% of the company's stock is held by institutional investors, 10.07% is held by insiders, and 78.41% is held by public companies and individual investors.
What percentage of Fennec Pharmaceuticals (TSE:FRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.52% of Fennec Pharmaceuticals (TSE:FRX) stock is held by institutional investors: 5.04% by mutual funds and 6.48% by ETFs.
What percentage of Fennec Pharmaceuticals (TSE:FRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 78.41% of Fennec Pharmaceuticals (TSE:FRX) stock is held by public companies and individual investors.
Who owns the most shares of Fennec Pharmaceuticals (TSE:FRX)?
Southpoint Capital Advisors Lp owns the most shares of Fennec Pharmaceuticals (TSE:FRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
